In particular, we have previously shown that HMGA2 overexpression positively correlated with the body mass index suggesting that the combined evaluation of HMGA2 expression and obesity can be considered a marker of poor prognosis in patients affected by ovarian carcinoma [15]. This evidence concerns the gene HMGA2 and obesity due to melanocortin 4 receptor deficiency.